Synthszr Charts — die großen AI-Marken im Wettkampf ums Podium

AI Agent Studio

Oracle · 4× · naposledy 21. 7. 2026

Momentum

Oracle AI Agent Studio is a design-time environment integrated into Oracle Fusion Cloud Applications that enables customers and partners to create, configure, test, deploy, and manage AI agents and agent teams. The platform provides native access to Fusion Applications' APIs, data models, security roles, and business logic, along with pre-built agent templates, multi-agent workflows, and—starting in 2026—an additional "Agentic Applications Builder." It is provided at no additional cost with the Fusion Cloud subscription, supports multiple LLM providers (including OpenAI, Anthropic, Google, Meta, xAI, and Cohere), and integrates external tools via the Model Context Protocol (MCP).

Vývoj momenta

20.05.18.08.

Vlastnosti

Autonomy Level	Autonomous execution triggered by events, schedules or emails, plus multi-agent workflows with human checkpoints and approvals
Channels	Chat/Ask Oracle, email, Microsoft Teams; planned: WhatsApp, SMS, telephony
License	Proprietary, part of Oracle Fusion SaaS Cloud subscription; custom agents may require a separate Custom AI Agent subscription
Modalities	Multimodal enhancements: end-user Q&A over images/documents uploaded in chat and semantic search across non-text assets
Platform	Natively integrated into Oracle Fusion Cloud Applications (SaaS), accessed via Navigator > Tools > AI Agent Studio
Price	Included at no additional cost with Fusion Cloud subscription; basic LLM (GPT-OSS) includes 20,000 AI Units/month at no charge, additional usage billed (SKU B112536)
Release Date	March 20, 2025 (initial announcement); expansions in Oct. 2025 and March 2026
Tool/MCP Integrations	MCP support for connecting external data/tools; tools include Business Object, Document, Email, Calculator, Deep Link, External REST

Další produkty v této kategorii: Frameworky pro agenty

Zdroje (4)

Company Analysis: Oracle

As of 07/08/2026

HOLDSynthszr Vote

Oracle’s operating momentum and visibility are strong on disclosed metrics (FY2027 guidance of $90B revenue and $8.05 non‑GAAP EPS; RPO of $638B). (investor.oracle.com) However, the dominant incremental variable for equity holders over the next 6–18 months is not demand but financing/cash-flow mechanics: elevated capex, planned debt/equity raising, and credit-metric sensitivity highlighted by S&P analysis. (investing.com) With valuation screens showing a mid‑teens to high‑teens forward P/E, the stock can work if execution is clean, but the risk-adjusted stance is HOLD until quarterly evidence shows capex intensity and adjusted leverage are stabilizing while OCI growth and margins remain consistent. (stockanalysis.com)

Summary

Oracle Corporation is a global enterprise software and cloud services provider with a large installed base in databases, middleware, and ERP/HCM applications, increasingly monetized through subscription cloud delivery (Oracle Cloud Infrastructure/OCI and Oracle Cloud Applications). The company’s core competencies remain mission‑critical database technology, integrated enterprise application suites, and vertically oriented solutions (including healthcare via Cerner), with a strategic emphasis on scaling OCI for AI training/inference workloads and large contracted capacity deals. Market position is differentiated by (1) deep enterprise relationships and high switching costs in database/application estates, (2) an integrated stack (database + apps + infrastructure) that can simplify procurement and operations for regulated customers, and (3) rapidly expanding OCI capacity tied to multi‑year contracts. Recent disclosures highlight exceptionally large contracted demand: Oracle reported remaining performance obligations (RPO) of $638B, materially above many expectations, positioning backlog as a key near‑term narrative driver. (investing.com) However, the investment debate has shifted toward the financing and cash flow implications of the AI infrastructure buildout. In the most recent earnings cycle (Q4 and FY2026 results released June 10, 2026), Oracle reported record results and reiterated FY2027 total revenue guidance of $90B while raising FY2027 non‑GAAP EPS guidance to $8.05 (management framing this as ~18% growth after adjusting for one‑time items). (investor.oracle.com) Reuters coverage emphasized capex and funding: Oracle indicated fiscal 2027 capex plans above Street expectations and referenced raising nearly $40B via debt/equity financing in 2027, reflecting the scale of AI datacenter investment. (investing.com) Credit risk has become more salient: S&P Global Ratings commentary and related reporting point to stretched credit metrics and the sensitivity of free cash flow to the pace of infrastructure spending and lease-like commitments. (spglobal.com) On valuation, recent market data sources show Oracle trading at roughly mid‑teens to high‑teens forward P/E (depending on estimate set/date) and mid‑20s trailing P/E, implying the market is discounting both strong earnings growth and elevated balance‑sheet/cash‑flow risk. (stockanalysis.com) With current price requested “in EUR,” a practical reference is Oracle’s NYSE quote of $126.41 (as of July 17, 2026 close per Oracle IR) and the ECB EUR/USD reference rate around 1.1389 USD per EUR (July 27, 2026), implying ~€111 per share on a simple spot conversion (illustrative, not a live quote). (investor.oracle.com) Outlook (short‑ to medium‑term) is primarily governed by (a) OCI capacity delivery and conversion of RPO into recognized revenue, (b) operating leverage versus depreciation/hosting costs, and (c) financing conditions (debt/equity issuance, credit rating trajectory). The near‑term setup is attractive if backlog converts on schedule and margins hold, but risk‑adjusted returns depend on whether capex intensity and funding needs stabilize before credit metrics deteriorate further.

Key Takeaways

Oracle’s growth narrative is increasingly OCI/AI-led, supported by very large contracted backlog (RPO reported at $638B), which is central to the revenue visibility argument. (investing.com)
FY2027 guidance is a key anchor: management confirmed $90B total revenue guidance and raised non‑GAAP EPS guidance to $8.05. (investor.oracle.com)
Capex and funding are the main investor constraint: Reuters reported Oracle expects to raise nearly $40B via debt/equity in 2027 and flagged capex above expectations. (investing.com)
Credit and cash-flow scrutiny is rising: S&P analysis indicates Oracle’s credit metrics may remain stretched for multiple years given AI infrastructure commitments and debt-like financing structures. (spglobal.com)
Valuation appears less demanding than many large-cap software peers on forward earnings (mid‑teens to high‑teens forward P/E in recent datasets), but that discount reflects financing/cash-flow risk rather than a pure growth skepticism. (stockanalysis.com)

Action Ideas

BUY

Data-driven upside case: Oracle has reiterated FY2027 revenue guidance of $90B and raised FY2027 non‑GAAP EPS guidance to $8.05, while reporting a very large RPO base ($638B) that supports multi‑year revenue visibility. If OCI capacity comes online as planned and backlog converts without disproportionate margin erosion, the current forward earnings multiple (recently reported in the mid‑teens to high‑teens range) can support attractive total return potential versus large-cap software peers. Key monitoring items are quarterly OCI growth, RPO conversion, and operating margin trajectory versus hosting/depreciation costs.

Horizon: 18 mo.

HOLD

Base-case positioning: Maintain exposure while requiring evidence that cash flow and leverage stabilize. Oracle’s guidance ($90B FY2027 revenue; $8.05 FY2027 non‑GAAP EPS) and backlog are supportive, but the market’s focus is on the financing burden and free-cash-flow profile during the AI datacenter buildout. A HOLD stance is justified if you want participation in OCI-led growth while waiting for clearer quarterly proof points on capex normalization, funding mix, and credit trajectory.

Horizon: 12 mo.

SELL

Risk-control case: Reduce exposure if your mandate prioritizes balance-sheet resilience and near-term free cash flow. Recent reporting emphasizes capex above expectations and planned debt/equity raising in 2027, while credit analysis suggests metrics could remain stretched for several years. If financing conditions tighten or if OCI economics under-deliver (lower margins, slower conversion of RPO), equity downside can be driven by both earnings risk and multiple compression.

Horizon: 6 mo.

Contrarian Insights

• Contrarian (more constructive): The market may be over-penalizing Oracle for capex while underweighting the earnings guideposts already provided (FY2027 revenue $90B; non‑GAAP EPS $8.05) and the scale of contracted demand (RPO $638B). If OCI buildout is substantially pre-sold, the capex profile can be interpreted as capacity investment with clearer monetization than typical speculative expansion. (investor.oracle.com)
• Contrarian (more cautious): Even with record RPO, the equity risk may be less about demand and more about the durability of free cash flow after accounting for debt-like financing structures and lease commitments. S&P’s framing that adjusted leverage could remain stretched for multiple years suggests that headline earnings growth may not translate into balance-sheet improvement on the timeline equity holders expect. (spglobal.com)